{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:14:16Z","timestamp":1778559256748,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"DOI":"10.1007\/s00417-026-07244-x","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:00:07Z","timestamp":1778558407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early macular choroidal hemodynamic changes after faricimab loading in treatment-na\u00efve diabetic macular edema"],"prefix":"10.1007","author":[{"given":"Kazufumi","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moe","family":"Nunose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serika","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuya","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"7244_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556\u2013564. https:\/\/doi.org\/10.2337\/dc11-1909","journal-title":"Diabetes Care"},{"key":"7244_CR2","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1097\/iae.0000000000001158","volume":"36","author":"RF Spaide","year":"2016","unstructured":"Spaide RF (2016) Retinal vascular cystoid macular edema: review and new theory. Retina 36:1823\u20131842. https:\/\/doi.org\/10.1097\/iae.0000000000001158","journal-title":"Retina"},{"key":"7244_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamaophthalmol.2017.6565","volume":"136","author":"NM Bressler","year":"2018","unstructured":"Bressler NM, Beaulieu WT, Glassman AR et al (2018) Persistent macular thickening following intravitreous aflibercept, bevacizumab, or ranibizumab for central-involved diabetic macular edema with vision impairment: a secondary analysis of a randomized clinical trial. JAMA Ophthalmol 136:257\u2013269. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.6565","journal-title":"JAMA Ophthalmol"},{"key":"7244_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10384-017-0537-6","volume":"62","author":"H Terasaki","year":"2018","unstructured":"Terasaki H, Ogura Y, Kitano S, Sakamoto T, Murata T, Hirakata A, Ishibashi T (2018) Management of diabetic macular edema in Japan: a review and expert opinion. Jpn J Ophthalmol 62:1\u201323. https:\/\/doi.org\/10.1007\/s10384-017-0537-6","journal-title":"Jpn J Ophthalmol"},{"key":"7244_CR5","doi-asserted-by":"publisher","unstructured":"Yoshida S, Murakami T, Nozaki M et al. (2021) Review of clinical studies and recommendation for a therapeutic flow chart for diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 259:815\u2013836. https:\/\/doi.org\/10.1007\/s00417-020-04936-w","DOI":"10.1007\/s00417-020-04936-w"},{"key":"7244_CR6","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.15252\/emmm.201505889","volume":"8","author":"JT Regula","year":"2016","unstructured":"Regula JT, Lundh von Leithner P, Foxton R et al (2016) Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases. EMBO Mol Med 8:1265\u20131288. https:\/\/doi.org\/10.15252\/emmm.201505889","journal-title":"EMBO Mol Med"},{"key":"7244_CR7","doi-asserted-by":"publisher","unstructured":"Heier JS, Singh RP, Wykoff CC et al. (2021) The angiopoietin\/tie pathway in retinal vascular diseases: A review. Retina 41:1\u201319. https:\/\/doi.org\/10.1097\/iae.0000000000003003","DOI":"10.1097\/iae.0000000000003003"},{"key":"7244_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/s0140-6736(22)00018-6","volume":"399","author":"CC Wykoff","year":"2022","unstructured":"Wykoff CC, Abreu F, Adamis AP et al (2022) Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials. Lancet 399:741\u2013755. https:\/\/doi.org\/10.1016\/s0140-6736(22)00018-6","journal-title":"Lancet"},{"key":"7244_CR9","doi-asserted-by":"publisher","unstructured":"Wong TY, Haskova Z, Asik K et al. (2024) Faricimab treat-and-extend for diabetic macular edema: Two-year results from the randomized Phase 3 YOSEMITE and RHINE trials. Ophthalmology 131:708\u2013723. https:\/\/doi.org\/10.1016\/j.ophtha.2023.12.026","DOI":"10.1016\/j.ophtha.2023.12.026"},{"key":"7244_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s1350-9462(00)00027-6","volume":"20","author":"DY Yu","year":"2001","unstructured":"Yu DY, Cringle SJ (2001) Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res 20:175\u2013208. https:\/\/doi.org\/10.1016\/s1350-9462(00)00027-6","journal-title":"Prog Retin Eye Res"},{"key":"7244_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0161-6420(85)34013-7","volume":"92","author":"AA Hidayat","year":"1985","unstructured":"Hidayat AA, Fine BS (1985) Diabetic choroidopathy. Light and electron microscopic observations of seven cases. Ophthalmology 92:512\u2013522. https:\/\/doi.org\/10.1016\/S0161-6420(85)34013-7","journal-title":"Ophthalmology"},{"key":"7244_CR12","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00417-016-3360-8","volume":"254","author":"D Melancia","year":"2016","unstructured":"Melancia D, Vicente A, Cunha JP, Abeg\u00e3o Pinto L, Ferreira J (2016) Diabetic choroidopathy: a review of the current literature. Graefes Arch Clin Exp Ophthalmol 254:1453\u20131461. https:\/\/doi.org\/10.1007\/s00417-016-3360-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7244_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1136\/bjo.2003.035345","volume":"88","author":"T Nagaoka","year":"2004","unstructured":"Nagaoka T, Kitaya N, Sugawara R (2004) Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol 88:1060\u20131063. https:\/\/doi.org\/10.1136\/bjo.2003.035345","journal-title":"Br J Ophthalmol"},{"key":"7244_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9496242","volume":"2020","author":"L Toto","year":"2020","unstructured":"Toto L et al (2020) Changes in ocular blood flow after ranibizumab intravitreal injection for diabetic macular edema measured using laser speckle flowgraphy. Biomed Res Int 2020:9496242. https:\/\/doi.org\/10.1155\/2020\/9496242","journal-title":"Biomed Res Int"},{"key":"7244_CR15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00417-018-3939-3","volume":"256","author":"M Okamoto","year":"2018","unstructured":"Okamoto M, Yamashita M, Ogata N (2018) Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 256:885\u2013892. https:\/\/doi.org\/10.1007\/s00417-018-3939-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7244_CR16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1755-3768.2009.01586.x","volume":"88","author":"T Sugiyama","year":"2010","unstructured":"Sugiyama T, Araie M, Riva CE, Schmetterer L, Orgul S (2010) Use of laser speckle flowgraphy in ocular blood flow research. Acta Ophthalmol 88:723\u2013729. https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01586.x","journal-title":"Acta Ophthalmol"},{"key":"7244_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ajoc.2016.08.002","volume":"4","author":"R Hashimoto","year":"2016","unstructured":"Hashimoto R, Hirota A, Maeno T (2016) Choroidal blood flow impairment demonstrated using laser speckle flowgraphy in a case of commotio retinae. Am J Ophthalmol Case Rep 4:30\u201334. https:\/\/doi.org\/10.1016\/j.ajoc.2016.08.002","journal-title":"Am J Ophthalmol Case Rep"},{"key":"7244_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ajoc.2017.10.010","volume":"8","author":"R Hashimoto","year":"2017","unstructured":"Hashimoto R, Kawamura J, Hirota A, Oyamada M, Sakai A, Maeno T (2017) Changes in choroidal blood flow and choroidal thickness after treatment in two cases of pediatric anisohypermetropic amblyopia. Am J Ophthalmol Case Rep 8:39\u201343. https:\/\/doi.org\/10.1016\/j.ajoc.2017.10.010","journal-title":"Am J Ophthalmol Case Rep"},{"key":"7244_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/vision4020031","volume":"4","author":"R Yamazaki","year":"2020","unstructured":"Yamazaki R, Hashimoto R, Masahara H, Sakamoto M, Maeno T (2020) Time course in ocular blood flow and pulse waveform in a case of ocular ischemic syndrome with intraocular pressure fluctuation. Vision 4:31. https:\/\/doi.org\/10.3390\/vision4020031","journal-title":"Vision"},{"key":"7244_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2020.100911","volume":"20","author":"K Yata","year":"2020","unstructured":"Yata K, Hashimoto R, Masahara H, Oyamada M, Maeno T (2020) Changes in choroidal circulation and pulse waveform in a case of pregnancy-induced hypertension with serous retinal detachment. Am J Ophthalmol Case Rep 20:100911. https:\/\/doi.org\/10.1016\/j.ajoc.2020.100911","journal-title":"Am J Ophthalmol Case Rep"},{"key":"7244_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14202328","volume":"14","author":"R Hashimoto","year":"2024","unstructured":"Hashimoto R, Aso K, Yata K et al (2024) Baseline choroidal blood flow imbalance as a predictive factor for macular edema recurrence secondary to branch retinal vein occlusion. Diagnostics 14:2328. https:\/\/doi.org\/10.3390\/diagnostics14202328","journal-title":"Diagnostics"},{"key":"7244_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14222484","volume":"14","author":"R Hashimoto","year":"2024","unstructured":"Hashimoto R, Aso K, Yata K et al (2024) Influence of aflibercept on choroidal blood flow and thickness in branch retinal vein occlusion: a six-month follow-up study. Diagnostics (Basel) 14:2484. https:\/\/doi.org\/10.3390\/diagnostics14222484","journal-title":"Diagnostics (Basel)"},{"key":"7244_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/micc.70048","volume":"33","author":"R Hashimoto","year":"2026","unstructured":"Hashimoto R, Oka R, Fujioka N et al (2026) Impact of androgen deprivation therapy on choroidal microcirculation assessed using laser speckle flowgraphy. Microcirculation 33:1. https:\/\/doi.org\/10.1111\/micc.70048","journal-title":"Microcirculation"},{"key":"7244_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33450-2","volume":"13","author":"K Okamoto","year":"2023","unstructured":"Okamoto K, Takahashi N, Kobayashi T, Shiba T, Hori Y, Fujii H (2023) Novel superpixel method to visualize fundus blood flow resistivity in healthy adults. Sci Rep 13:6171. https:\/\/doi.org\/10.1038\/s41598-023-33450-2","journal-title":"Sci Rep"},{"key":"7244_CR25","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.1111\/aos.12298","volume":"92","author":"VP Costa","year":"2014","unstructured":"Costa VP, Harris A, Anderson D et al (2014) Ocular perfusion pressure in glaucoma. Acta Ophthalmol 92:e252-266. https:\/\/doi.org\/10.1111\/aos.12298","journal-title":"Acta Ophthalmol"},{"key":"7244_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1167\/iovs.11-8782","volume":"53","author":"CS Tan","year":"2012","unstructured":"Tan CS, Ouyang Y, Ruiz H, Sadda SR (2012) Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 53:261\u2013266. https:\/\/doi.org\/10.1167\/iovs.11-8782","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7244_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000000519","volume":"94","author":"T Iwase","year":"2015","unstructured":"Iwase T, Yamamoto K, Ra E, Murotani K, Matsui S, Terasaki H (2015) Diurnal variations in blood flow at optic nerve head and choroid in healthy eyes: diurnal variations in blood flow. Medicine (Baltimore) 94:e519. https:\/\/doi.org\/10.1097\/md.0000000000000519","journal-title":"Medicine (Baltimore)"},{"key":"7244_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2025.100744","volume":"5","author":"V Chaudhary","year":"2025","unstructured":"Chaudhary V, Guymer R, Artignan A, Downey A, Singh RP (2025) Real-world evidence for faricimab in neovascular age-related macular degeneration and diabetic macular edema: A scoping review. Ophthalmol Sci 5:100744. https:\/\/doi.org\/10.1016\/j.xops.2025.100744","journal-title":"Ophthalmol Sci"},{"key":"7244_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0014-4835(91)90256-e","volume":"52","author":"ME Langham","year":"1991","unstructured":"Langham ME, Grebe R, Hopkins S, Marcus S, Sebag M (1991) Choroidal blood flow in diabetic retinopathy. Exp Eye Res 52:167\u2013173. https:\/\/doi.org\/10.1016\/0014-4835(91)90256-e","journal-title":"Exp Eye Res"},{"key":"7244_CR30","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1007\/s00417-021-05292-z","volume":"259","author":"S Kase","year":"2021","unstructured":"Kase S, Endo H, Takahashi M et al (2021) Choroidal vascular structures in diabetic patients: A meta-analysis. Graefes Arch Clin Exp Ophthalmol 259:3537\u20133548. https:\/\/doi.org\/10.1007\/s00417-021-05292-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7244_CR31","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.66.3.50","volume":"66","author":"E Sadeghi","year":"2025","unstructured":"Sadeghi E, Du K, Ajayi O et al (2025) Three-dimensional choroidal vessels assessment in diabetic retinopathy. Invest Ophthalmol Vis Sci 66:50. https:\/\/doi.org\/10.1167\/iovs.66.3.50","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"7244_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10384-024-01078-y","volume":"68","author":"M Shimura","year":"2024","unstructured":"Shimura M, Oh H, Ueda T et al (2024) Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in diabetic macular edema: 2-year results from the Japan subgroup of the phase 3 YOSEMITE trial. Jpn J Ophthalmol 68:511\u2013522. https:\/\/doi.org\/10.1007\/s10384-024-01078-y","journal-title":"Jpn J Ophthalmol"},{"key":"7244_CR33","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.2147\/opth.S476307","volume":"18","author":"T Mizukami","year":"2024","unstructured":"Mizukami T, Mizumoto S, Ishibashi T et al (2024) Changes in ocular blood flow after intravitreal injection for diabetic macular edema between aflibercept and faricimab. Clin Ophthalmol 18:2407\u20132416. https:\/\/doi.org\/10.2147\/opth.S476307","journal-title":"Clin Ophthalmol"},{"key":"7244_CR34","doi-asserted-by":"publisher","unstructured":"34. Saima Y, Yokota H, Kushiyama A et al. (2024) Effects of switching from intravitreal injection of aflibercept to faricimab on ocular blood flow in patients with diabetic macular edema. Sci Rep 14:13798. https:\/\/doi.org\/10.1038\/s41598-024-63435-8","DOI":"10.1038\/s41598-024-63435-8"},{"key":"7244_CR35","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s00417-017-3692-z","volume":"255","author":"M Sugimoto","year":"2017","unstructured":"Sugimoto M, Nunome T, Sakamoto R, Kobayashi M, Kondo M (2017) Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye. Graefes Arch Clin Exp Ophthalmol 255:1543\u20131550. https:\/\/doi.org\/10.1007\/s00417-017-3692-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7244_CR36","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1097\/IAE.0b013e31822c28d6","volume":"32","author":"H Hosseini","year":"2012","unstructured":"Hosseini H, Lotfi M, Esfahani M et al (2012) Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration. Retina 32:967\u2013971. https:\/\/doi.org\/10.1097\/IAE.0b013e31822c28d6","journal-title":"Retina"},{"key":"7244_CR37","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/bjophthalmol-2014-305252","volume":"98","author":"RL Avery","year":"2014","unstructured":"Avery RL, Castellarin AA, Steinle NC et al (2014) Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD. Br J Ophthalmol 98:1636\u20131641. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305252","journal-title":"Br J Ophthalmol"},{"key":"7244_CR38","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00417-014-2717-0","volume":"252","author":"I Yoshida","year":"2014","unstructured":"Yoshida I, Shiba T, Taniguchi H et al (2014) Evaluation of plasma vascular endothelial growth factor levels after intravitreal injection of ranibizumab and aflibercept for exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 252:1483\u20131489. https:\/\/doi.org\/10.1007\/s00417-014-2717-0","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7244_CR39","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.ajo.2014.06.009","volume":"158","author":"X Wang","year":"2014","unstructured":"Wang X, Sawada T, Sawada O, Saishin Y, Liu P, Ohji M (2014) Serum and plasma vascular endothelial growth factor concentrations before and after intravitreal injection of aflibercept or ranibizumab for age-related macular degeneration. Am J Ophthalmol 158:738-744.e1. https:\/\/doi.org\/10.1016\/j.ajo.2014.06.009","journal-title":"Am J Ophthalmol"},{"key":"7244_CR40","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910666","volume":"11","author":"JT Regula","year":"2019","unstructured":"Regula JT, Lundh von Leithner P, Foxton R et al (2019) Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases. EMBO Mol Med 11:e10666. https:\/\/doi.org\/10.15252\/emmm.201910666","journal-title":"EMBO Mol Med"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07244-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07244-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07244-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:00:13Z","timestamp":1778558413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07244-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":40,"alternative-id":["7244"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07244-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. All data were anonymized, and no identifying information is included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The study protocol was approved by the Ethics Committee of the Faculty of Medicine, Toho University (approval number: T2024-4180; 6 November 2025). The requirement for informed consent was waived by the Ethics Committee of the Faculty of Medicine, Toho University, due to the retrospective nature of the study, and an opt-out option was provided on the institutional website. The study was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}